IGC Pharma Inc (IGC)
0.5104
-0.01
(-1.85%)
USD |
NYAM |
May 10, 16:00
0.5104
0.00 (0.00%)
After-Hours: 19:52
IGC Pharma Cash from Investing (Quarterly): -0.061M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.061M |
| September 30, 2023 | 0.072M |
| June 30, 2023 | -0.005M |
| March 31, 2023 | -0.242M |
| December 31, 2022 | -0.017M |
| September 30, 2022 | 0.182M |
| June 30, 2022 | -0.158M |
| March 31, 2022 | -0.553M |
| December 31, 2021 | -0.049M |
| September 30, 2021 | -0.045M |
| June 30, 2021 | -0.095M |
| March 31, 2021 | 1.928M |
| December 31, 2020 | 1.654M |
| September 30, 2020 | 0.941M |
| June 30, 2020 | -1.136M |
| March 31, 2020 | -0.741M |
| December 31, 2019 | -1.695M |
| September 30, 2019 | -0.925M |
| June 30, 2019 | -6.186M |
| March 31, 2019 | -0.211M |
| December 31, 2018 | -0.033M |
| September 30, 2018 | -0.008M |
| June 30, 2018 | -0.008M |
| March 31, 2018 | -0.356M |
| December 31, 2017 | -0.153M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.1441M |
| June 30, 2017 | -0.0039M |
| March 31, 2017 | 0.0293M |
| December 31, 2016 | -0.1153M |
| September 30, 2016 | -0.0375M |
| June 30, 2016 | -0.1178M |
| March 31, 2016 | -0.2184M |
| December 31, 2015 | -0.0116M |
| September 30, 2015 | 0.073M |
| June 30, 2015 | -0.0264M |
| March 31, 2015 | 0.1988M |
| December 31, 2014 | -0.0128M |
| September 30, 2014 | -0.5793M |
| June 30, 2014 | -0.1248M |
| March 31, 2014 | 0.0031M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.4477M |
| December 31, 2012 | 0.0605M |
| September 30, 2012 | 0.064M |
| June 30, 2012 | 0.2485M |
| March 31, 2012 | 0.439M |
| December 31, 2011 | 4.191M |
| September 30, 2011 | 0.0182M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-6.186M
Minimum
Jun 2019
1.928M
Maximum
Mar 2021
-0.3753M
Average
-0.061M
Median
Dec 2023
Cash from Investing (Quarterly) Benchmarks
| CEL-SCI Corp | -0.0649M |
| AIM ImmunoTech Inc | -0.214M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Protalix BioTherapeutics Inc | -0.342M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.587M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -6.55M |
| Free Cash Flow Per Share (Quarterly) | -0.0263 |
| Free Cash Flow to Equity (Quarterly) | -1.673M |
| Free Cash Flow to Firm (Quarterly) | -1.674M |
| Free Cash Flow Yield | -22.90% |